BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33068774)

  • 1. Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease.
    Mello A; Hsu MF; Koike S; Chu B; Cheng J; Yang J; Morisseau C; Torok NJ; Hammock BD; Haj FG
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):815-830. PubMed ID: 33068774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
    Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury.
    Bettaieb A; Koike S; Chahed S; Zhao Y; Bachaalany S; Hashoush N; Graham J; Fatima H; Havel PJ; Gruzdev A; Zeldin DC; Hammock BD; Haj FG
    FEBS J; 2017 Jul; 284(13):1970-1986. PubMed ID: 28485854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.
    Warner JB; Hardesty JE; Song YL; Floyd AT; Deng Z; Jebet A; He L; Zhang X; McClain CJ; Hammock BD; Warner DR; Kirpich IA
    Am J Pathol; 2024 Jan; 194(1):71-84. PubMed ID: 37925018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
    Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
    Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
    Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
    Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
    Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice.
    Bettaieb A; Chahed S; Bachaalany S; Griffey S; Hammock BD; Haj FG
    Mol Pharmacol; 2015 Aug; 88(2):281-90. PubMed ID: 25993999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
    Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
    J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue.
    Bettaieb A; Nagata N; AbouBechara D; Chahed S; Morisseau C; Hammock BD; Haj FG
    J Biol Chem; 2013 May; 288(20):14189-14199. PubMed ID: 23576437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
    López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.
    Bettaieb A; Koike S; Hsu MF; Ito Y; Chahed S; Bachaalany S; Gruzdev A; Calvo-Rubio M; Lee KSS; Inceoglu B; Imig JD; Villalba JM; Zeldin DC; Hammock BD; Haj FG
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2758-2765. PubMed ID: 28757338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase inhibitor attenuates BBB disruption and neuroinflammation after intracerebral hemorrhage in mice.
    Tian Y; Yuan X; Wang Y; Wu Q; Fang Y; Zhu Z; Song G; Xu L; Wang W; Xie M
    Neurochem Int; 2021 Nov; 150():105197. PubMed ID: 34592333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
    Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
    PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice.
    Hsu MF; Koike S; Mello A; Nagy LE; Haj FG
    Redox Biol; 2020 Sep; 36():101658. PubMed ID: 32769011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
    Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
    Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
    Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.